Could a stem cell transplant keep T-Cell lymphoma away longer?
NCT ID NCT06724237
First seen May 06, 2026 · Last updated May 14, 2026 · Updated 2 times
Summary
This study compares two approaches for people with peripheral T-cell lymphoma who are in complete remission after initial treatment: either high-dose chemotherapy followed by a transplant of their own stem cells, or simply watching and waiting. The goal is to see if the transplant helps keep the cancer from coming back longer. About 294 adults aged 18 to 75 with certain types of T-cell lymphoma will take part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANAPLASTIC LARGE CELL LYMPHOMA, ALK-NEGATIVE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Alaska Breast Care and Surgery LLC
RECRUITINGAnchorage, Alaska, 99508, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.